ARIEL LEPAK: Open Payments
NPI 1215521257 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 32 payments from 14 companies in 2025. Trend: 2023 $454 · 2024 $435 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $187 |
| Neurocrine BioSciences, Inc. | 1 | $157 |
| Axsome Therapeutics, Inc. | 3 | $142 |
| ABBVIE INC. | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Alkermes, Inc. | 4 | $100 |
| Almatica Pharma LLC | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Lundbeck LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: AUSTEDO XR, INGREZZA, Auvelity, VRAYLAR, REXULTI, ARISTADA, LOREEV XR, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
